A common, normally dormant virus called cytomegalovirus can make matters worse for patients with critical illness — and a new study by Fred Hutch's Dr. Michael Boeckh and colleagues at the University of Washington hints that preventing the virus from reawakening in these critical moments could stem some of its harm.
New analysis finds rare immune cells linked to HIV vaccine’s effectiveness
May 28, 2015
| By Dr. Rachel Tompa / Fred Hutch News Service
There are several kinds of immune responses that could protect against HIV infection. A new analysis has now found that a small but important subset of the immune cells known as T cells may be important for a working HIV vaccine.